Lupus Patients Have Higher Mortality Risk Following Coronary Revascularization
MD Magazine reports on an analysis of Medicaid Analytic eXtract (MAX) data led by Medha Barbhaiya, MD, MPH, rheumatologist at HSS, and presented at the American College of Rheumatology annual meeting, which compared patient outcomes in Medicaid patients with systemic lupus erythematosus (SLE), diabetes mellitus, and in the general population. Findings revealed that patients with SLE were at a two-fold increased risk of 30-day mortality following coronary revascularization.
This article originally appeared at MDmag.com.
Additional coverage: Healio Rheumatology, Bay News 9 (Tampa, FL.) during the 5pm news hour on November 13, 2019.